Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Axfood AB | Stockholm | Consumer Non-Cyclicals | Food & Drug Retailing | SEK 50.76B | 23.2x | -3.32 | SEK 231.70 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 1.5% Upside | Upgrade to Pro+ | |
Viva Wine AB | Stockholm | Consumer Non-Cyclicals | Food & Drug Retailing | SEK 3.38B | 30.9x | -1.28 | SEK 39 | 3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 35.3% Upside | Upgrade to Pro+ | |
EQL Pharma | Stockholm | Consumer Non-Cyclicals | Food & Drug Retailing | SEK 2.48B | 71.8x | 1.2 | SEK 85.40 | -2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -9.3% Downside | Upgrade to Pro+ | |
AcuCort | Spotlight | Consumer Non-Cyclicals | Food & Drug Retailing | SEK 98.67M | -5.9x | -0.11 | SEK 0.83 | -3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Newbury Pharmaceuticals AB | Stockholm | Consumer Non-Cyclicals | Food & Drug Retailing | SEK 81.51M | -4.9x | -0.29 | SEK 3.26 | -3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |